515 related articles for article (PubMed ID: 27038189)
21. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
22. Effects of Low-Level Blast on Neurovascular Health and Cerebral Blood Flow: Current Findings and Future Opportunities in Neuroimaging.
Kilgore MO; Hubbard WB
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203813
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD.
Bryant AG; Manhard MK; Salat DH; Rosen BR; Hyman BT; Johnson KA; Huang S; Bennett RE; Yen YF
Curr Alzheimer Res; 2021; 18(9):711-720. PubMed ID: 34825871
[TBL] [Abstract][Full Text] [Related]
24. Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer's disease.
Habib M; Mak E; Gabel S; Su L; Williams G; Waldman A; Wells K; Ritchie K; Ritchie C; O'Brien JT
Ageing Res Rev; 2017 Jul; 36():88-104. PubMed ID: 28342882
[TBL] [Abstract][Full Text] [Related]
25. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.
Wierenga CE; Hays CC; Zlatar ZZ
J Alzheimers Dis; 2014; 42 Suppl 4(Suppl 4):S411-9. PubMed ID: 25159672
[TBL] [Abstract][Full Text] [Related]
26. Endothelial Dysfunction in Neurodegenerative Diseases.
Fang YC; Hsieh YC; Hu CJ; Tu YK
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769234
[TBL] [Abstract][Full Text] [Related]
27. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.
Nation DA; Sweeney MD; Montagne A; Sagare AP; D'Orazio LM; Pachicano M; Sepehrband F; Nelson AR; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Chui HC; Law M; Toga AW; Zlokovic BV
Nat Med; 2019 Feb; 25(2):270-276. PubMed ID: 30643288
[TBL] [Abstract][Full Text] [Related]
28. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
Fisher RA; Miners JS; Love S
Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
[TBL] [Abstract][Full Text] [Related]
29. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.
Canepa E; Fossati S
Front Neurol; 2020; 11():573324. PubMed ID: 33488493
[TBL] [Abstract][Full Text] [Related]
30. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
31. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
Boese AC; Hamblin MH; Lee JP
Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
[TBL] [Abstract][Full Text] [Related]
32. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
[TBL] [Abstract][Full Text] [Related]
33. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
34. Vascular-water-exchange MRI (VEXI) enables the detection of subtle AXR alterations in Alzheimer's disease without MRI contrast agent, which may relate to BBB integrity.
Zhang Y; Wang Y; Li Z; Wang Z; Cheng J; Bai X; Hsu YC; Sun Y; Li S; Shi J; Sui B; Bai R
Neuroimage; 2023 Apr; 270():119951. PubMed ID: 36805091
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
[TBL] [Abstract][Full Text] [Related]
36. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
[TBL] [Abstract][Full Text] [Related]
38. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
39. MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.
Raja R; Rosenberg GA; Caprihan A
Neuropharmacology; 2018 May; 134(Pt B):259-271. PubMed ID: 29107626
[TBL] [Abstract][Full Text] [Related]
40. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
